Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Hermeking

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 15, 2025
Five-Gene Expression Signature Associated With Acquired FOLFIRI Resistance and Survival in Metastatic Colorectal CancerElise Pretzsch, Christiane A Peschel, Matjaz Rokavec, et al.
The Journal of Experimental Medicine|June 12, 2013
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancerRene Jackstadt, Simone Röh, Jens Neumann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 17, 2004
Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylationPaulette Mhawech, Ana Benz, Christelle Cerato, et al.
Cancer Research|October 11, 2022
SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and MetastasisLeon P Loevenich, Markus Tschurtschenthaler, Matjaz Rokavec, et al.
Plos One|January 4, 2013
Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancerLydia Kriegl, Andreas Jung, David Horst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2018
PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal CancerSebastian Lamprecht, Markus Kaller, Eva Marina Schmidt, et al.
Molecular & Cellular Proteomics : MCP|July 18, 2015
p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) AnalysesSabine Hünten, Markus Kaller, Friedel Drepper, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2011
Wild-type p53 controls cell motility and invasion by dual regulation of MET expressionChang-Il Hwang, Andres Matoso, David C Corney, et al.
Cell Reports|March 18, 2014
miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartmentChieh-Yang Cheng, Chang-Il Hwang, David C Corney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2016
ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal CancerCristina Blaj, Agnes Bringmann, Eva Marina Schmidt, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 15, 2025
Five-Gene Expression Signature Associated With Acquired FOLFIRI Resistance and Survival in Metastatic Colorectal CancerElise Pretzsch, Christiane A Peschel, Matjaz Rokavec, et al.
The Journal of Experimental Medicine|June 12, 2013
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancerRene Jackstadt, Simone Röh, Jens Neumann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 17, 2004
Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylationPaulette Mhawech, Ana Benz, Christelle Cerato, et al.
Cancer Research|October 11, 2022
SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and MetastasisLeon P Loevenich, Markus Tschurtschenthaler, Matjaz Rokavec, et al.
Plos One|January 4, 2013
Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancerLydia Kriegl, Andreas Jung, David Horst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2018
PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal CancerSebastian Lamprecht, Markus Kaller, Eva Marina Schmidt, et al.
Molecular & Cellular Proteomics : MCP|July 18, 2015
p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) AnalysesSabine Hünten, Markus Kaller, Friedel Drepper, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2011
Wild-type p53 controls cell motility and invasion by dual regulation of MET expressionChang-Il Hwang, Andres Matoso, David C Corney, et al.
Cell Reports|March 18, 2014
miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartmentChieh-Yang Cheng, Chang-Il Hwang, David C Corney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2016
ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal CancerCristina Blaj, Agnes Bringmann, Eva Marina Schmidt, et al.
Pageof 12